Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Tumori|May 7, 2016
New drugs in the treatment of elderly patients with metastatic castration-resistance prostate cancerGiovenzio Genestreti, Monica Di Battista, Giovanna Cavallo, et al.
Expert Review of Anticancer Therapy|June 2, 2015
Maintenance therapy in non-small cell lung cancerGiovenzio Genestreti, Monica Di Battista, Giovanna Cavallo, et al.
Cancer|March 17, 2004
A multicenter study of the prognosis and treatment of adult brain ependymal tumorsMichele Reni, Alba Ariela Brandes, Vittorio Vavassori, et al.
Future Oncology (London, England)|November 15, 2014
Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overviewGiovenzio Genestreti, Francesco Grossi, Carlo Genova, et al.
Journal of Neuro-Oncology|April 29, 2006
Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumorsLuciano Scopece, Enrico Franceschi, Giovanna Cavallo, et al.
Journal of Neuro-Oncology|June 28, 2005
Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosisEnrico Franceschi, Giovanna Cavallo, Luciano Scopece, et al.
Cancer|May 25, 2005
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Giovanna Cavallo, Michele Reni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-OncologiaAlba A Brandes, Umberto Basso, Michele Reni, et al.
Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative groupMarco Benasso, Anna Ponzanelli, Marco Merlano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO studyAlba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Pageof 2